Wang Jian serves as Chairman and Co-founder of BGI Group. In 1999, Wang Jian co-founded the Beijing Genomics Institute (BGI) to undertake China’s portion of the Human Genome Project. Under his leadership, BGI grew into one of the world’s leading genomics organizations, driving large-scale research a...
Dr. Peng Zhiyu, a research scientist at BGI Genomics Co., Ltd. in Shenzhen, focuses on the application of multi-omics technologies in the prevention and control of genetic disorders. He has led his team in developing a new thalassemia screening technology based on high-throughput sequencing, which h...
Dr Li Ning takes responsibility on BGI Global Development management as Vice President in BGI Group. As a member of the committee of International Rare Disease Research Consortium (IRDiRC), he takes a leading role in the global development on BGI community of precision medicine.
Mr. Sujie Cao (Jeremy) serves as General Manager for Asia-Pacific at BGI Genomics, leading the company’s development across Southeast Asia and the wider region. He has led the development of research and diagnostic platforms across Southeast Asia including Thailand, Indonesia, and Vietnam, advancing...
Mr. Xiaohan Wang is the Official Representative of BGI Group Thailand. He leads the company’s strategic development and partnerships across Southeast Asia and the wider Asia-Pacific region, advancing collaboration in genetic testing, public health, and scientific research.
Mr. Cheng Le serves as General Manager of BGI Southwest Region. He leads the development of precision medicine and genetic testing in Southwest China, fostering close collaboration with government, healthcare, and research sectors.